About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Still Awaits SIAC Arbitration Update

June 8, 2018

Click here to read more

Post navigation

Retirement of Non-Executive Director

Research Report from NDF Research

Related Posts

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Avecho reaches two-year stability milestone for its CBD softgel capsule

June 22, 2023June 22, 2023

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.